EssilorLuxottica

EL

FR0000121667

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 11:35:25 2024-04-23 am EDT			After market 12:56:25 pm
204.8 ^EUR	+0.89%		204.8	0.00%

Apr. 22	White Pearl Technology Group Bags Digital Marketing Contract from EssilorLuxottica	MT
Apr. 19	ESSILORLUXOTTICA : No major surprises in the Q1

ESSILORLUXOTTICA : RBC sticks Neutral

August 02, 2021 at 08:17 am EDT

Analyst Piral Dadhania from RBC research gives the stock a Neutral rating. The target price has been raised from EUR 160 to EUR 170.

Latest news about EssilorLuxottica

White Pearl Technology Group Bags Digital Marketing Contract from EssilorLuxottica	Apr. 22	MT
ESSILORLUXOTTICA : No major surprises in the Q1	Apr. 19
Global markets live: P&G, Amex, Blackstone, Apple, Tesla...	Apr. 19
ESSILORLUXOTTICA : UBS gives a Neutral rating	Apr. 19	ZD
ESSILORLUXOTTICA : UBS reiterates its recommendation on the stock	Apr. 19	CF
ESSILORLUXOTTICA : Receives a Buy rating from Goldman Sachs	Apr. 19	ZD
ESSILORLUXOTTICA : JP Morgan reiterates its Buy rating	Apr. 19	ZD
EssilorLuxottica Q1 Revenue Rises, Outlook Affirmed	Apr. 18	MT
ESSILORLUXOTTICA : Jefferies remains Neutral	Apr. 18	ZD
ESSILORLUXOTTICA : RBC sticks Neutral	Apr. 18	ZD
Meta releases early versions of its Llama 3 AI model	Apr. 18	RE
ESSILORLUXOTTICA : UBS sticks Neutral	Apr. 18	ZD
EssilorLuxottica Upbeat on Long-Term Outlook After Revenue Increase-- Update	Apr. 18	DJ
EssilorLuxottica Upbeat on Long-Term Outlook After Revenue Increase	Apr. 18	DJ
EssilorLuxottica: confirms sales growth target	Apr. 18	CF
Transcript : EssilorLuxottica Société anonyme, Q1 2024 Sales/ Trading Statement Call, Apr 18, 2024	Apr. 18
Ray-Ban maker EssilorLuxottica's revenues rose 5.5% in first quarter	Apr. 18	RE
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	Apr. 18
EssilorLuxottica Announces Revenue Results for the First Quarter of 2024	Apr. 18	CI
Meta releases early versions of its Llama 3 AI model	Apr. 18	RE
EMEA Morning Briefing : Stocks Seen Broadly Higher as Focus Shifts to Earnings	Apr. 18	DJ
Inspecs hails "encouraging" recent trading after tepid start to 2024	Apr. 17	AN
France's CDC Increases Stake in EssilorLuxottica, Il Sole24 Ore Reports	Apr. 11	DJ
Deals of the day-Mergers and acquisitions	Apr. 09	RE
EssilorLuxottica buys Japan's Washin to expand its retail presence	Apr. 09	RE

EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, the company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux® and Transitions®, and world-class retail brands including Sunglass Hut and LensCrafters are part of the EssilorLuxottica family.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-30 - Annual General Meeting

Related indices

CAC 40 , EURO STOXX 50 , STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ESSILORLUXOTTICA : No major surprises in the Q1

April 19, 2024 at 10:12 am EDT

More Strategies

Ratings for EssilorLuxottica

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

203 EUR

Average target price

205.9 EUR

Spread / Average Target

+1.43%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
ESSILORLUXOTTICA	+12.78%	97.69B
ALCON INC.	+12.40%	39.6B
THE COOPER COMPANIES, INC.	-3.56%	17.9B
AUTEK CHINA INC.	-23.03%	2.12B
WARBY PARKER INC.	-5.46%	1.46B
PEGAVISION CORPORATION	+21.69%	1.09B
MINGYUE OPTICAL LENS CO.,LTD.	-38.53%	759M
MENICON CO., LTD.	-36.57%	740M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-12.09%	613M
VIZIONFOCUS INC.	+19.80%	468M

Glasses, Spectacles & Contact Lenses